AI stock analysis for US and Swedish equities

TellStocks.com is an AI stock research tool that runs multi-lens analysis on valuation, fundamentals, and catalysts to help investors make clearer decisions.

Enter a ticker to open the app and start analysis in one step.
Swedish stock analysis US stock analysis Valuation models Fundamental research Catalyst tracking

Built for retail and professional investors

Clarity first: you see the why behind every recommendation.

  • Multi-lens AI research with audit-ready sources
  • Valuation zones, bull/bear cases, and watchpoints
  • Consistent framework across US and Swedish equities

How it works

The workflow starts with your inputs and model setup, gathers evidence across lenses, summarizes each lens, and synthesizes a final recommendation with valuation, confidence, and risk context.

Workflow: inputs and model setup, evidence gathering per lens, and synthesis into a final report.

Multi-lens AI research

Blend valuation, fundamentals, and catalysts into one coherent report.

US + Swedish coverage

Analyze US and OMX equities with the same consistent framework.

Actionable insights

Get clear bull/bear cases, key watchpoints, and price zones.

Portfolio ready

Save analyses, revisit history, and track the ideas that matter.

For long-term investors

Use TellStocks.com to validate conviction trades or build a watchlist of high-quality companies with defensible valuation ranges.

For active decision-makers

Spot catalysts, stress-test assumptions, and compare how different research lenses change your recommendation.

What this app does

TellStocks.com is an AI stock research platform for US and Swedish equities. It runs multi-lens analysis with source-backed summaries, valuation ranges, bull/bear cases, catalyst watchpoints, and portfolio-ready tracking.

Who it’s for

Built for retail investors, active traders, finance students, and analysts who want structured research across US and Swedish stocks.

Why it exists

To make stock decisions more transparent by turning scattered data into a clear, evidence-backed investment thesis.